Live from the NIH registry
Studies recruiting near Shreveport right now
Top 25 of 159 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Medtronic
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
N/A
Observational 100 participants sought
Ochsner LSU Health Science Center Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Innoviva Specialty Therapeutics
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Shreveport, LA — Shreveport, Louisiana (4.9 mi)
· Sponsor: Mediar Therapeutics
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Overton Brooks V.A. Medical Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Novo Nordisk A/S
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers
Pressure Injury
N/A
Interventional 10 participants sought
MedCentris of Bossier City — Bossier City, Louisiana (5.1 mi)
· Sponsor: NuScience Medical Biologics, LLC
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer
Phase 3
Interventional 600 participants sought
Research Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: AstraZeneca
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
Degenerative Disc Disease (DDD)
N/A
Interventional 225 participants sought
Spine Institute of Louisiana (The Spine Network) — Shreveport, Louisiana (4.9 mi)
· Sponsor: ReGelTec, Inc.
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: GlaxoSmithKline
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: NRG Oncology
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Colorectal Cancer
Phase 4
Interventional 78 participants sought
Willis Knighton Cancer Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Takeda
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC)
Phase 2
Interventional 140 participants sought
Mirador Therapeutics Selected Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Mirador Therapeutics, Inc.
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Kailera
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Trials365 LLC — Shreveport, Louisiana (4.9 mi)
· Sponsor: Daiichi Sankyo
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Northwest Louisiana Nephrology — Shreveport, Louisiana (4.9 mi)
· Sponsor: Boehringer Ingelheim
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
Northwest Louisiana Nephrology — Shreveport, Louisiana (4.9 mi)
· Sponsor: Takeda
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Phase 2, Phase 3
Interventional 176 participants sought
Northwest Louisiana Nephrology, LLC - Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Lupus Nephritis
Phase 2
Interventional 40 participants sought
Louisiana State University — Shreveport, Louisiana (4.9 mi)
· Sponsor: Hoffmann-La Roche
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
Louisiana State University Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Mercy Health Ohio
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Alnylam Pharmaceuticals
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Endometrial Cancer
Phase 3
Interventional 480 participants sought
WK Cancer Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: BioNTech SE
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: GlaxoSmithKline
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: AstraZeneca
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Breast Neoplasms, Carcinoma, Ductal, Breast
N/A
Interventional 725 participants sought
Willis Knighton Cancer Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Natera, Inc.
Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease
Degenerative Disc Disease
Phase 3
Interventional 316 participants sought
LSU Health — Shreveport, Louisiana (4.9 mi)
· Sponsor: CGBio Inc.